glp 1 agonist and dpp 4 inhibitor Comparison of GLP-1 receptor agonists DPP-4 inhibitors The DPP-4 inhibitor linagliptin and

In the brain, the two incretins are not redundant and may complement each other in regulating orexigenic and anorexigenic pathways (148)

Cenicriviroc is a dual CCR2/CCR5 antagonist

It is not a GLP-1-only agonist, but it is often discussed alongside GLP-1 medications because many of the benefits and side effects overlap

Mechanisms of action of GLP-1, GIP and GCG receptors in human target organs

This analysis also indicated that sitagliptin was the only DPP-4 inhibitor that improved insulin resistance when used as monotherapy

GLP-1 agonists are used to help manage type 2 diabetes and obesity as well as a few other conditions